Bamboo US BidCo LLC drugs
14 results
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, and certain solid tumors. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who have not responded to corticosteroid therapy. Safety in adults for nephrotic syndrome is unestablished.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for the treatment of various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and several cancers such as ovarian and breast carcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who do not respond to corticosteroids.
Dapzura rt (daptomycin)
(daptomycin)Bamboo US BidCo LLC
Usage: DAPZURA RT is indicated for treating complicated skin and skin structure infections in adults and pediatric patients (1-17 years) caused by certain Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. It also treats Staphylococcus aureus bloodstream infections in adults and pediatric patients. It is not for pneumonia or left-sided endocarditis.
Flucelvax (influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/sydney/1304/2022 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated))
(INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Sydney/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED))Bamboo US BidCo LLC
Fluzone quadrivalent northern hemisphere (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/darwin/9/2021 san-010 (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
(INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))Bamboo US BidCo LLC
Fluzone trivalent (influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/california/122/2022 san-022 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
(INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/California/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))Bamboo US BidCo LLC
Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)
(Human Papillomavirus 9-valent Vaccine, Recombinant)Bamboo US BidCo LLC
Hyqvia (immune globulin infusion 10% (human) with recombinant human hyaluronidase)
(Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase)Bamboo US BidCo LLC
Ifosfamide (ifosfamide)
(ifosfamide)Bamboo US BidCo LLC
Usage: Ifosfamide for Injection is indicated for third-line chemotherapy of germ cell testicular cancer, used in combination with specific approved antineoplastic agents and mesna to prevent hemorrhagic cystitis.